Journal of Diagnostics Concepts & Practice >
Application of metabolomics of different biological samples in study of OSAHS biomarkers
Received date: 2021-04-01
Online published: 2022-11-07
The obstructive sleep apnea-hypopnea syndrome(OSAHS) is a sleep disorder caused by upper airway stenosis, and the main clinical manifestations were apnea, hypopnea, and arousal. In recent years, the incidence of OSAHS shows increasing trend, while its clinical diagnosis method is still relatively simple, and the early accurate diagnosis cannot be achieved. Metabolomics has played an important role in many disciplines such as medicine, pharmacy, and toxicology as an emerging subject, even if its research develops relatively short time. In this paper, we systematically reviewed the studies and applications of metabolomics on OSAHS biomarkers and found that OSAHS could cause changes in some special metabolites, including amino acids, lipids, acylcarnitines, intestinal flora, phospholipids, aromatic hydrocarbons, saturated hydrocarbons, acetone and isoprene. These metabolites involved in various metabolic pathways and mechanisms such as amino acid metabolism, lipid metabolism, oxidative stress pathway, phospholipid metabolism and endocannabinoids. The differential metabolites existed in a variety of biological samples in patients, including blood, urine, feces, saliva, and tonsil tissue, and some metabolites could be used in the early diagnosis and differential diagnosis of OSAHS and as the reference for further research on the biomarkers and pathogenesis of OSAHS.
Key words: Metabolomics; Metabolites; OSAHS; Biomarkers
ZHOU Sifeng, XU Haishu, FAN Xinsheng . Application of metabolomics of different biological samples in study of OSAHS biomarkers[J]. Journal of Diagnostics Concepts & Practice, 2022 , 21(04) : 535 -540 . DOI: 10.16150/j.1671-2870.2022.04.021
[1] | Zhang P, Georgiou CA, Brusic V. Elemental metabolomics[J]. Brief Bioinform, 2018, 19(3):524-536. |
[2] | 唐玥, 韩宇博, 隋艳波, 等. 代谢组学技术在代谢综合征诊疗中的应用进展[J]. 医学综述, 2022, 28(3):579-583. |
[2] | Tang Y, Han YB, Sui YB, et al. Application progress of metabonomics technology in the diagnosis and treatment of metabolic syndrome[J]. Med Rev, 2022, 28(3): 579-583. |
[3] | Kennedy AD, Wittmann BM, Evans AM, et al. Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing[J]. Mass Spectrom, 2018, 53(11):1143-1154. |
[4] | Chen YC, Hsu PY, Hsiao CC, et al. Epigenetics: A potential mechanism involved in the pathogenesis of various adverse consequences of obstructive sleep apnea[J]. Int J Mol Sci, 2019, 20(12):2937. |
[5] | 阻塞性睡眠呼吸暂停低通气综合征诊治指南基层版写作. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)[J]. 中国呼吸与危重监护杂志, 2015, 14(4):398-405. |
[5] | Guidelines for the diagnosis and treatment of obstructive sleep apnea hypopnea syndrome(Basic Edition)[J]. Chin J Respir Crit Care, 2015, 14 (4): 398-405. |
[6] | Selmi C, Montano N, Furlan R, et al. Inflammation and oxidative stress in obstructive sleep apnea syndrome[J]. Exp Biol Med (Maywood), 2007, 232(11):1409-1413. |
[7] | Xu H, Zheng X, Jia W, et al. Chromatography/mass spectrometry-based biomarkers in the field of obstructive sleep apnea[J]. Medicine(Baltimore), 2015, 94(40):e1541. |
[8] | Pugliese G, Barrea L, Laudisio D, et al. Sleep apnea, obesity, and disturbed glucose homeostasis: epidemiologic evidence, biologic insights, and therapeutic strategies[J]. Curr Obes Rep, 2020, 9(1):30-38. |
[9] | Ma XR, Wang Y, Sun YC. Imbalance of osteoprotegerin/receptor activator of nuclear factor-κB ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome[J]. Chin Med J (Engl), 2019, 132(1):25-29. |
[10] | Kapur VK, Auckley DH, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An american academy of sleep medicine clinical practice guideline[J]. J Clin Sleep Med, 2017, 13(3):479-504. |
[11] | 罗雪梅. 代谢组学技术及其在产科的应用[J]. 国际妇产科学杂志, 2011, 38(5): 378-382. |
[11] | Luo XM. Metabonomics technology and its application in obstetrics[J]. Internl J Obstet Gynecol, 2011, 38(5):378-382. |
[12] | Emwas AH. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research[J]. Methods Mol Biol, 2015, 1277:161-193. |
[13] | 贾伟. 医学代谢组学[M]. 上海: 上海科学技术出版社, 2011:98-127. |
[13] | Jia W. Medical metabolomics[M]. Shanghai: Shanghai Science and Technology Press, 2011:98-127. |
[14] | Engeli S, Blüher M, Jumpertz R, et al. Circulating anandamide and blood pressure in patients with obstructive sleep apnea[J]. J Hypertens, 2012, 30(12):2345-2351. |
[15] | Lebkuchen A, Carvalho VM, Venturini G, et al. Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk[J]. Sci Rep, 2018, 8(1):11270. |
[16] | Ferrarini A, Rupérez FJ, Erazo M, et al. Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study[J]. Electrophoresis, 2013, 34(19):2873-2881. |
[17] | Jordan W, Berger C, Cohrs S, et al. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome[J]. J Neural Transm (Vienna), 2004, 111(6):683-689. |
[18] | Niu X, Chen X, Xiao Y, et al. The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis[J]. PLoS One, 2014, 9(4):e95794. |
[19] | Li K, Zhang J, Qin Y, et al. Sociation between serum homocysteine level and obstructive sleep apnea: A meta-analysis[J]. Biomed Res Int, 2017, 2017:7234528. |
[20] | Chen X, Niu X, Xiao Y, et al. Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: a meta-analysis[J]. Sleep Breath, 2014, 18(4):687-694. |
[21] | Day RM, Matus IA, Suzuki YJ, et al. Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive sleep apnoea[J]. Respirology, 2009, 14(8):1134-1142. |
[22] | Zhou L, Chen P, Peng Y, et al. Role of oxidative stress in the neurocognitive dysfunction of obstructive sleep apnea syndrome[J]. Oxid Med Cell Longev, 2016, 2016:9626831. |
[23] | Dikmenoiğlu N, Ciftçi B, Ileri E, et al. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome[J]. Sleep Med, 2006, 7(3):255-261. |
[24] | Kobayashi M, Miyazawa N, Takeno M, et al. Circulating carbon monoxide level is elevated after sleep in patients with obstructive sleep apnea[J]. Chest, 2008, 134(5):904-910. |
[25] | O′Driscoll DM, Horne RS, Davey MJ, et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications[J]. Sleep Med, 2011, 12(5):483-488. |
[26] | Paik MJ, Kim DK, Nguyen DT, et al. Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea[J]. Sleep Breath, 2014, 18(3):517-523. |
[27] | Monneret D, Pepin JL, Godin-Ribuot D, et al. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients[J]. Free Radic Biol Med, 2010, 48(4):619-625. |
[28] | Xu H, Zheng X, Qian Y, et al. Metabolomics profiling for obstructive sleep apnea and simple snorers[J]. Sci Rep, 2016, 6:30958. |
[29] | Xu H, Li X, Zheng X, et al. Pediatric obstructive sleep apnea is associated with changes in the oral microbiome and urinary metabolomics profile: A pilot study[J]. J Clin Sleep Med, 2018, 14(9):1559-1567. |
[30] | Kawai M, Kirkness JP, Yamamura S, et al. Increased phosphatidylcholine concentration in saliva reduces surface tension and improves airway patency in obstructive sleep apnoea[J]. J Oral Rehabil, 2013, 40(10):758-766. |
[31] | Ezzedini R, Darabi M, Ghasemi B, et al. Tissue fatty acid composition in obstructive sleep apnea and recurrent tonsillitis[J]. Int J Pediatr Otorhinolaryngol, 2013, 77(6):1008-1012. |
[32] | Papandreou C. Independent associations between fatty acids and sleep quality among obese patients with obstructive sleep apnoea syndrome[J]. J Sleep Res, 2013, 22(5):569-572. |
[33] | Zɖbek A, Stanimirova I, Deja S, et al. Fusion of the 1 H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome[J]. Metabolomics, 2015, 11(6):1563-1574. |
[34] | Tripathi A, Xu ZZ, Xue J, et al. Intermittent hypoxia and hypercapnia reproducibly change the gut microbiome and metabolome across rodent model systems[J]. mSystems, 2019, 4(2):e00058-19. |
[35] | Zhang A, Sun H, Yan G, et al. Metabolomics for biomarker discovery: Moving to the clinic[J]. Biomed Res Int, 2015, 2015:354671. |
/
〈 |
|
〉 |